Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it is highlighting its diverse portfolio of orthopedic and musculoskeletal innovations at the ...

Equities researchers at Zacks Research cut their Q1 2025 earnings per share (EPS) estimates for Zimmer Biomet in a report ...

President and Chief Executive Officer at Zimmer Biomet. "We are in the midst of one of the largest innovation cycles in our company's history. Our broad hip reconstruction portfolio combined with ...

Assetmark Inc. decreased its position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 67.7% in the 4th quarter, ...

Orthopedic surgery is a marvelous field because we can make meaningful improvements in the comfort and function of patients ...

Stryker continues to enjoy extensive financial flexibility, even as it has issued more debt to finance the purchase of some larger acquisitions. At the end of 2024, the firm's net debt/EBITDA was 1.9 ...

John Goodman sadly sustained a hip injury while working on Alejandro González Iñárritu and Tom Cruise’s new film in the UK.

While commercial insurers often use prior authorization as a way to control costs, it does the opposite for patients undergoing total hip arthroplasty, according to a study presented at the 2025 ...